BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29806632)

  • 21. Improved Detection of
    Katano I; Ito R; Kawai K; Takahashi T
    Front Immunol; 2020; 11():532684. PubMed ID: 33117338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological responses against hepatitis B virus in human peripheral blood mononuclear cell-engrafted mice.
    Aono S; Tatsumi T; Yoshioka T; Tawara S; Nishio A; Onishi Y; Fukutomi K; Nakabori T; Kodama T; Shigekawa M; Hikita H; Sakamori R; Takahashi T; Suemizu H; Takehara T
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1457-1464. PubMed ID: 30033102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.
    Ito M; Kobayashi K; Nakahata T
    Curr Top Microbiol Immunol; 2008; 324():53-76. PubMed ID: 18481452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
    Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
    Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice.
    Camacho RE; Wnek R; Shah K; Zaller DM; O'Reilly RJ; Collins N; Fitzgerald-Bocarsly P; Koo GC
    Cell Immunol; 2004; 232(1-2):86-95. PubMed ID: 15922719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models.
    Maser IP; Hoves S; Bayer C; Heidkamp G; Nimmerjahn F; Eckmann J; Ries CH
    Front Immunol; 2020; 11():2082. PubMed ID: 33013879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells.
    Büchner SM; Sliva K; Bonig H; Völker I; Waibler Z; Kirberg J; Schnierle BS
    Clin Exp Immunol; 2013 Aug; 173(2):355-64. PubMed ID: 23607364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse.
    Katano I; Nishime C; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M; Takahashi T
    Sci Rep; 2017 Dec; 7(1):17230. PubMed ID: 29222435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice.
    Ito R; Takahashi T; Katano I; Kawai K; Kamisako T; Ogura T; Ida-Tanaka M; Suemizu H; Nunomura S; Ra C; Mori A; Aiso S; Ito M
    J Immunol; 2013 Sep; 191(6):2890-9. PubMed ID: 23956433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse.
    Kametani Y; Shiina M; Katano I; Ito R; Ando K; Toyama K; Tsukamoto H; Matsumura T; Saito Y; Ishikawa D; Taki T; Ito M; Imai K; Tokuda Y; Kato S; Tamaoki N; Habu S
    Exp Hematol; 2006 Sep; 34(9):1240-8. PubMed ID: 16939817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease.
    Geraghty NJ; Belfiore L; Ly D; Adhikary SR; Fuller SJ; Varikatt W; Sanderson-Smith ML; Sluyter V; Alexander SI; Sluyter R; Watson D
    Clin Exp Immunol; 2017 Oct; 190(1):79-95. PubMed ID: 28665482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of human spleen into immunodeficient NOD/SCID IL2Rγ(null) mice generates humanized mice that improve functional B cell development.
    Chung YS; Son JK; Choi B; Park JB; Chang J; Kim SJ
    Clin Immunol; 2015 Dec; 161(2):308-15. PubMed ID: 26360254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human B cell growth and differentiation in the spleen of immunodeficient mice.
    Depraetere S; Verhoye L; Leclercq G; Leroux-Roels G
    J Immunol; 2001 Mar; 166(5):2929-36. PubMed ID: 11207241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells.
    Yacoub-Youssef H; Marcheix B; Calise D; Thiers JC; Therville N; Benoist H; Blaes N; Ségui B; Dambrin C; Thomsen M
    Transpl Immunol; 2005 Dec; 15(2):157-64. PubMed ID: 16412960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porcine cell microchimerism but lack of productive porcine endogenous retrovirus (PERV) infection in naive and humanized SCID-beige mice treated with porcine peripheral blood mononuclear cells.
    Kuddus RH; Metes DM; Nalesnik MA; Logar AJ; Rao AS; Fung JJ
    Transpl Immunol; 2004; 13(1):15-24. PubMed ID: 15203124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOD-Rag2null IL-2Rγnull mice: an alternative to NOG mice for generation of humanized mice.
    Katano I; Ito R; Kamisako T; Eto T; Ogura T; Kawai K; Suemizu H; Takahashi T; Kawakami Y; Ito M
    Exp Anim; 2014; 63(3):321-30. PubMed ID: 25077762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice.
    Suemizu H; Hasegawa M; Kawai K; Taniguchi K; Monnai M; Wakui M; Suematsu M; Ito M; Peltz G; Nakamura M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):248-52. PubMed ID: 18840406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a β-cell neo-self-antigen in type 1 diabetes prone NOD mice.
    Cox SL; Stolp J; Hallahan NL; Counotte J; Zhang W; Serreze DV; Basten A; Silveira PA
    Eur J Immunol; 2010 Dec; 40(12):3413-25. PubMed ID: 21108464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved B cell development in humanized NOD
    Jangalwe S; Shultz LD; Mathew A; Brehm MA
    Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.